Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mayapada Hospital operates seven premium hospitals across Indonesia with over 1,000 beds as of late 2024. The group has established centers of excellence in oncology and cardiology and offers advanced radiotherapy facilities. Its flagship Jakarta Selatan unit holds Joint Commission International accreditation. The company has seen significant expansion since its founding in 2008 and recently secured $157 million from Bain Capital to further grow its footprint[3][7].
Clinical results are measured by patient satisfaction indices—recent process improvements have raised customer satisfaction scores from ~87% to ~95% between late–2022 and mid–2024[5]. The oncology center provides comprehensive cancer care including early detection through LDCT scans and advanced interventional pulmonology such as Bronchoscopic Cryotherapy[6].
Strategic partnerships include Apollo Hospitals for clinical program development in oncology, cardiology, neurology, transplant surgery; technology integration includes AI-driven hospital information systems[4][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mayapada Hospital.